During the past decade, Ikebukuro Metropolitan Clinic conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ikebukuro Metropolitan Clinic" are "Diabetes Mellitus, Type 2" (1 trials), "Hot Flashes" (1 trials), "Leiomyoma" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "Ikebukuro Metropolitan Clinic" in a lesser frequency.

Most popular intervention types in "Ikebukuro Metropolitan Clinic" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bexagliflozin tablets" (1 trials), "Bexagliflozin tablets, placebo" (1 trials), "Dulaglutide" (1 trials), "Fezolinetant" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ikebukuro Metropolitan Clinic" are 2 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ikebukuro Metropolitan Clinic". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ikebukuro Metropolitan Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ikebukuro Metropolitan Clinic, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".